Promino Nutritional Sciences

MUSL

The current Promino Nutritional Sciences (MUSL) market capitalization is approximately CA$4.77M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Promino Nutritional Sciences's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:41 PM Eastern Time

In the most recently reported quarter, Promino Nutritional Sciences (MUSL) generated CA$841.01K in revenue, representing a +542.68% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:22 AM Eastern Time

In the most recently reported fiscal year, Promino Nutritional Sciences (MUSL) generated net income of CA$-7.41M, compared with CA$-5.81M in the prior fiscal year, representing a -27.59% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:22 AM Eastern Time

In the most recently reported quarter, Promino Nutritional Sciences (MUSL) revenue was CA$841.01K. Earnings per share (EPS) for the quarter were CA$0.00. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:22 AM Eastern Time

Promino Nutritional Sciences (MUSL) does not currently pay a dividend. Over the last twelve months (LTM), the company paid CA$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 2:22 AM Eastern Time

Based on the latest available analyst coverage, Promino Nutritional Sciences (MUSL) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated:

Like other publicly traded stocks, Promino Nutritional Sciences (MUSL) shares are bought and sold on stock exchanges such as CNSX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Promino Nutritional Sciences (MUSL) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add MUSL to your watchlist.

Promino Nutritional Sciences trades under the ticker symbol MUSL on the CNSX stock exchange. The ticker MUSL is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Promino Nutritional Sciences (MUSL) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Promino Nutritional Sciences (MUSL) stock peers based on overlapping products, services, and competitive dynamics:Vitality Products (VPI)Provexis (PXS)Psyched Wellness (PSYC)Nutritional Growth Solutions (NGS)BioHarvest Sciences (BHST)Genix Pharmaceuticals (GENX) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Promino Nutritional Sciences.